References:
[1] Coronavirus disease 2019 (COVID-19) Situation Report – 79.
World Health Organization. April 13, 2020
[2] M.Li, L. Chen, C. Xiong, X. Li .The ACE2 expression of
maternal-fetal interface and fetal organs indicates potential risk of
vertical transmission of SARS-COV-2. bioRxiv preprint doi:
https://doi.org/10.1101/2020.02.27.967760.
[3] L.
Anton
, D.C.
Merrill
, L.A.
Neves
, et al., Activation of Local Chorionic Villi Angiotensin II Levels But
Not Angiotensin (1-7) in Preeclampsia. Hypertension. 2008;
51(4):1066-72.doi: 10.1161/HYPERTENSIONAHA.107.103861.Epub 2008 Feb 7.
[4]
Q.Lu, Y.
Shi.
Coronavirus disease (COVID‐19) and neonate: What neonatologist need to
know.
J
Med Virol. 2020. doi: 10.1002/jmv.25740.
[5] L.
Panahi, M.
Amiri, S.
Pouy.
Risks of Novel Coronavirus Disease (COVID-19) in Pregnancy; a Narrative
Review.
Arch
Acad Emerg Med. 2020;8(1):e34. eCollection 2020
[6] S. Colaco, K. Chhbria, N. Singh et.al., Expression of SARS-CoV-2
receptor ACE2 and the spike protein processing enzymes in developing
human embryos.
arXiv:2004.04935 [q-bio.TO]
[7] R.R.
Bhonde,
U.V. Wagh.
Susceptibility of human placenta to Japanese encephalitis virus in
vitro.
Indian
J Med Res. 1985;82:371-3.
[8] R.S.
Al-Lamki, J.R.
Bradley, J.S.
Pober.
Human Organ Culture: Updating the Approach to Bridge the Gap from In
Vitro to In Vivo in Inflammation, Cancer, and Stem Cell Biology. Front
Med (Lausanne). 2017; 11(4):148. doi: 10.3389/fmed.2017.00148.
eCollection 2017.